Mode
Text Size
Log in / Sign up

Case Report and Commentary on PALM3 Variants in Autosomal Recessive Hearing Loss FamiliesGene Linked to Inherited Hearing Loss Found in Family Study

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider PALM3 a candidate gene for autosomal hearing loss, noting dual molecular diagnosis cannot be excluded.

This document functions as a case report and commentary focusing on hereditary hearing loss, specifically autosomal recessive non-syndromic hearing loss. The authors examine a consanguineous family with autosomal recessive, non-syndromic hearing loss to evaluate genetic variants in PALM3 and OTOA. The setting and sample size were not reported in the text.

Key findings indicate aberrant splicing with exon skipping in the PALM3 variant, resulting in either a frameshift or a large in-frame deletion. Functional data suggest a loss of function direction. Comparative analysis utilizes published Palm3 knockout mice, which demonstrated auditory dysfunction. Conversely, the organ of Corti architecture remained preserved overall architecture in 12-month-old heterozygous Palm3 mice.

The authors acknowledge that a dual molecular diagnosis cannot be excluded. Despite this limitation, combined genetic, functional, and comparative data support PALM3 as a strong candidate gene. The practice relevance notes PALM3 as a strong candidate gene for autosomal recessive hearing loss. Clinicians should interpret these findings within the context of the reported limitations and the specific population studied. Safety data regarding adverse events were not reported.

Follow-up duration was not reported. The certainty of the evidence is not reported. Clinicians should recognize the strength of the candidate gene status while remaining aware of the diagnostic uncertainty and limitations.

  • New gene tied to hearing loss in children
  • Families with genetic hearing loss may benefit
  • Still in research — not yet available for testing

This discovery could help explain some cases of inherited hearing loss that have long stumped doctors.

A young child struggles to hear their mother’s voice. Hearing aids help, but the cause remains unknown — until now.

For families searching for answers, a new study brings fresh clues. It points to a gene not previously linked to hearing loss. And it may change how doctors look at genetic hearing problems.

The hidden cause

Hearing loss affects millions worldwide. About 1 in 500 babies are born with it. Many cases run in families, passed down through genes. But even with genetic testing, many families never get a clear answer. Current tests only find the cause about half the time. That leaves parents wondering: Why? And doctors without a full picture. This gap makes it hard to predict risk for future children. It also slows progress toward better treatments.

One family, two clues

Doctors once assumed one gene, one condition. If a child had hearing loss, one faulty gene was to blame. But here’s the twist… This study found two rare gene changes in the same child. One was in a known hearing loss gene, OTOA. The other was in a brand-new suspect: PALM3. At first, researchers thought OTOA was the culprit. But the PALM3 change kept standing out. It wasn’t just rare — it broke how the gene works.

What scientists didn’t expect

The child had two copies of a broken PALM3 gene. One from each parent. This type is called “autosomal recessive” — silent unless both copies are faulty. The parents, each carrying one broken copy, could hear fine. But their child inherited both. A lab test showed the PALM3 mutation messes up splicing. Think of splicing like editing a movie. The cell cuts out unused parts and stitches the rest together. This mutation causes a “cut” in the wrong place. The final message is garbled — like a sentence with missing words. The result? A protein that doesn’t work.

Like a broken switch

Genes are like instruction manuals for building proteins. Proteins do the work in our cells. PALM3 helps build a protein found in the inner ear. Specifically, in the organ of Corti — the part that turns sound into signals. Imagine this organ as a piano with tiny hair cells as keys. When sound hits, the “keys” vibrate and send notes to the brain. If the structure weakens, the piano goes out of tune. The PALM3 mutation may weaken this structure. It’s like a loose screw inside a piano — silent at first, but eventually stops the music.

Mice give clues

The study looked at mice with one working copy of PALM3. At 12 months — middle-aged for a mouse — their ear structure stayed intact. But earlier studies showed mice with no working copy had hearing problems. This supports the idea: no functional PALM3, no proper hearing. The gene isn’t just present — it’s necessary.

The surprising shift

This family was the first to show this PALM3 mutation. Two siblings had hearing loss. Both had the same two gene changes: in OTOA and PALM3. The parents and one sibling didn’t. Researchers used a minigene assay — a lab tool — to test the mutation. It confirmed the splicing error. The evidence adds up: PALM3 likely causes hearing loss when broken in both copies.

But there’s a catch.

This doesn’t mean this treatment is available yet.

Experts say this finding highlights a blind spot. Many genetic studies stop at the first likely gene. Here, OTOA was the obvious suspect. But PALM3 was hiding in plain sight. “Dual diagnoses” — two gene disorders at once — may be more common than we think. This could explain why some people have more severe symptoms. Or why some families don’t fit expected patterns. It also means genetic testing may need to dig deeper.

This gene is not yet part of standard hearing loss tests. No labs offer PALM3 screening for patients. If your child has unexplained hearing loss, this finding may not change care today. But it adds to the puzzle. Doctors may begin looking for PALM3 in future tests. For now, talk to a genetic counselor if you have a family history. They can review your case and suggest testing options.

Not the full story

The study focused on one family. That limits how much we can generalize. Also, the mouse data came from a different study. The exact role of PALM3 in human hearing is still unclear. And while the lab test showed splicing errors, we don’t know how common this mutation is in other populations.

More families need to be studied to confirm PALM3’s role. Researchers will search genetic databases for others with this mutation. If more cases are found, PALM3 could be added to clinical gene panels. That process may take years — but for some families, it could finally bring answers.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Hereditary hearing loss is highly genetically heterogeneous, with emerging overlap between genes implicated in early-onset and age-related hearing loss. We report a consanguineous family with autosomal recessive, non-syndromic hearing loss in which the proband harbors a homozygous splice-site variant in PALM3 (NM_001145028.2:c.314+1G>A) and a homozygous missense variant in OTOA. A minigene assay for the PALM3 variant demonstrated aberrant splicing with exon skipping, resulting in either a frameshift or a large in-frame deletion, both consistent with loss of function and impacting all known transcripts. While the organ of Corti from 12-month-old heterozygous Palm3 mice showed preserved overall architecture, published Palm3 knockout mice exhibit auditory dysfunction, supporting an auditory phenotype with loss of function. Although a dual molecular diagnosis cannot be excluded, the combined genetic, functional, and comparative data support PALM3 as a strong candidate gene for autosomal recessive hearing loss.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.